IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


(Investigative Ophthalmology and Visual Science. 2007;48:1607-1614.)
© 2007 by The Association for Research in Vision and Ophthalmology, Inc.
DOI:  10.1167/iovs.06-0834

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (4)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chalasani, M. L.
Right arrow Articles by Swarup, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chalasani, M. L.
Right arrow Articles by Swarup, G.

A Glaucoma-Associated Mutant of Optineurin Selectively Induces Death of Retinal Ganglion Cells Which Is Inhibited by Antioxidants

Madhavi Latha Chalasani,1 Vegesna Radha,2 Vijay Gupta,2 Neeraj Agarwal,3 Dorairajan Balasubramanian,1 and Ghanshyam Swarup2

1From the L.V. Prasad Eye Institute, Hyderabad, India; the 2Centre for Cellular and Molecular Biology, Hyderabad, India; and the 3Department of Cell Biology and Genetics, University of North Texas Health Science Center, Fort Worth, Texas.

PURPOSE. Mutations in the coding region of the OPTN gene are associated with certain glaucomas. Although the function of the optineurin protein is yet to be elucidated, the most common mutation, E50K, is associated with a severe phenotype. This study explores some functional features of optineurin and its mutants.

METHODS. Plasmids expressing normal or wild-type (WT) and E50K, R545Q, H26D, and H486R mutant optineurin were transfected into HeLa, Cos-1, IMR32, and the rat retinal ganglion cell (RGC) line RGC-5, and their effects on cell survival monitored by morphologic observation of cells were studied. Expression of optineurin and its mutants was monitored by immunofluorescence staining of cells and by Western blotting.

RESULTS. The E50K mutant of optineurin selectively induced the death of retinal ganglion cells but not of the other cell lines tested. Although the expression of optineurin and E50K mutant suppressed cell death induced by tumor necrosis factor-{alpha} in HeLa cells, they potentiated this cell death in retinal ganglion cells. Cell death induced by the optineurin mutant in retinal ganglion cells was inhibited by the antioxidants N-acetylcysteine and Trolox. Reactive oxygen species (ROS) were produced upon expression of E50K, which were reduced by antioxidants. Coexpression of manganese superoxide dismutase with the E50K mutant abolished ROS production and inhibited cell death.

CONCLUSIONS. The E50K mutation of optineurin acquired the ability to induce cell death selectively in retinal ganglion cells. This cell death was mediated by oxidative stress. The present findings raise the possibility of antioxidant use for delaying or controlling some forms of glaucoma.





This article has been cited by other articles:


Home page
IOVSHome page
Y. He, K. W. Leung, Y.-H. Zhang, S. Duan, X.-F. Zhong, R.-Z. Jiang, Z. Peng, J. Tombran-Tink, and J. Ge
Mitochondrial Complex I Defect Induces ROS Release and Degeneration in Trabecular Meshwork Cells of POAG Patients: Protection by Antioxidants
Invest. Ophthalmol. Vis. Sci., April 1, 2008; 49(4): 1447 - 1458.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the Association for Research in Vision and Ophthalmology